We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




MIS Surgery for Atrial Fibrillation

By HospiMedica staff writers
Posted on 05 Sep 2005
A minimally invasive surgery (MIS) procedure called Mini-Maze corrects atrial fibrillation (AF) without the use of a heart/lung machine or a division or spreading of the ribs.

The Mini-Maze procedure uses new technology to interrupt the path of the aberrant electrical impulses. More...
A heart surgeon guides a thorascope and a special tool that grasps the heart's atrium at the top of the chamber. The special tool uses radiofrequency (RF) technology to destroy tissue where the irregular impulse starts. The damaged tissue can no longer conduct electrical impulses and the rest of the chamber resumes a normal rhythm. The procedure was pioneered by Dr. Randall Wolf, M.D., of the University Hospital in Cincinnati (OH, USA).

"For the first time we have a truly minimally invasive procedure that can permanently eliminate AF, return patients to their normal rhythm, and significantly reduce their risk of stroke,” commented Marc Gerdisch, M.D., director of cardiothoracic surgery at Central DuPage Hospital (Winfield, IL, USA). Dr. Gerdisch performed the Mini-Maze procedure on a patient in May 2005 who went back to work two days after surgery, was driving and gardening within one week, and is being weaned off AF medications.

Worldwide, the Mini-Maze procedure has been performed on more than 375 patients, with AF eliminated in more than 85% of these. "Until now, the options available to AF patients were unattractive at best: a lifetime of anticoagulant therapy, a permanent pacemaker, or a difficult, invasive operation,” noted Dr. Gerdisch. "The Mini-Max offers patients an optimal choice.”





Related Links:
University Hospital, Cincinnati
Central DuPage Hospital

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.